Mineralys Therapeutics (MLYS) Stock Chart & Stock Price History $14.60 +0.72 (+5.16%) As of 02:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Mineralys Therapeutics Stock Price Performance The Mineralys Therapeutics (MLYS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 16.77%, with a year-to-date return of 18.57%. In the past month, the stock has increased 7.88%, reflecting recent market activity. As of the latest close, Mineralys Therapeutics traded at $13.88 with a market cap of $904.70 million and volume of 619,548 shares. Receive MLYS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.93%1 Month Performance+7.88%3 Month Performance+2.72%Year-To-Date Performance+18.57%1 Year Performance+16.77% MLYS Stock Chart for Wednesday, July, 30, 2025 MLYS Chart by TradingView Mineralys Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/29/2025$13.60$13.88+2.06%$14.01$13.41619,548 shs$904.70 million07/28/2025$14.32$13.60-5.03%$14.45$13.54555,579 shs$886.38 million07/25/2025$14.26$14.32+0.42%$14.45$13.85558,890 shs$933.31 million07/24/2025$13.31$14.26+7.14%$14.55$13.13782,150 shs$929.47 million07/23/2025$13.34$13.31-0.22%$13.62$13.25729,853 shs$867.55 million07/22/2025$13.62$13.34-2.06%$13.90$13.28937,956 shs$869.43 million07/21/2025$14.23$13.62-4.29%$14.42$13.54590,117 shs$887.75 million07/18/2025$14.34$14.23-0.77%$14.74$14.14987,955 shs$927.51 million07/17/2025$14.32$14.34+0.14%$14.47$14.251.02 million shs$934.68 million07/16/2025$14.62$14.32-2.05%$14.80$14.16806,487 shs$933.31 million Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/15/2025$15.02$14.62-2.66%$15.24$14.40316,141 shs$952.93 million07/14/2025$14.49$15.02+3.66%$15.17$14.07518,994 shs$979.00 million07/11/2025$14.64$14.49-1.02%$14.94$14.30442,534 shs$944.46 million07/10/2025$14.37$14.64+1.88%$14.68$14.10364,126 shs$954.24 million07/09/2025$13.95$14.37+3.01%$14.53$13.85596,239 shs$936.64 million07/08/2025$13.53$13.95+3.10%$14.17$13.50767,190 shs$909.26 million07/07/2025$14.53$13.53-6.85%$14.70$13.44830,150 shs$881.89 million07/04/2025$14.53$14.53$14.63$14.20349,918 shs$946.74 million07/03/2025$14.30$14.53+1.57%$14.63$14.20349,918 shs$946.74 million07/02/2025$13.70$14.30+4.38%$14.54$13.65753,845 shs$932.07 million07/01/2025$13.53$13.70+1.26%$13.78$13.22717,345 shs$892.90 million06/30/2025$13.71$13.53-1.31%$13.98$13.37985,943 shs$881.89 million Related Companies VKTX Stock Chart SWTX Stock Chart AAPG Stock Chart PTGX Stock Chart MLTX Stock Chart HCM Stock Chart IMVT Stock Chart KYMR Stock Chart CRNX Stock Chart MOR Stock Chart Receive MLYS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MLYS) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredDrone Company Secures Major Defense Contract Amid Sweeping Policy ShiftOn July 10th, the White House and DoD announced a sweeping new directive to fast-track U.S. drone dominance. ...The Tomorrow Investor | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredStrange Investment Secret Predicts Market's Next Move?A strange market signal discovered before the Great Depression has predicted nearly every major financial even...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mineralys Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLYS Stock Alerts